Thyroshield

   
Google
 
Web NewDrugInformation.com

Thyroshield


Drug - Thyroshield
The trade name of the product as shown on the labeling.

Dosage - SOLUTION; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Potassium Iodide
Multiple ingredients are in alphabetical order.

Strength - 65MG/ML
The potency of the active ingredient(s), Potassium Iodide. May repeat for multiple part products.

Applicant - FLEMING
The firm name holding legal responsibility for Thyroshield. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 077218
The FDA assigned number to Thyroshield. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Thyroshield. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 12, 2005
The date Thyroshield was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Thyroshield. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - OTC
The group or category of approved drugs Thyroshield is in. Format is RX, OTC, DISCN.

Applicant Full Name - Fleming And Co Pharmaceuticals
The full name of the firm holding legal responsibility for the new application of Thyroshield.

Thyroshield